Driving reinvestment in R&D for antibiotics and advocating their responsible use

DRIVE-AB Progress and “Responsible Use of Antibiotics” Preliminary Findings Featured at ECCMID 2016

The DRIVE-AB consortium had a significant presence at this year’s European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) 2016 in Amsterdam, being featured at the European Network Corner, the Pipeline Corner and Pipeline Talk, and presenting a numerous abstracts.

The consortium presented a poster in the European Network Corner on DRIVE-AB’s progress to date. Please click here to see the overview of the project’s midterm progress.

DRIVE-AB Work Package 1A, ‘Responsible use of antibiotics, new and old’, presented preliminary results at the Congress; one oral presentation and four posters (details below) on quality and quantity indicators and metrics of antibiotic use in inpatient, outpatient and hospital settings were presented. These findings were also discussed in a DRIVE-AB Train-the-Trainer workshop, “Defining and implementing responsible antibiotic use”, for senior members of the European medical antibiotic stewardship community.

  1. Metrics for quantifying antimicrobial use in a hospital setting: results from a systematic review (poster)
  2. Quantity metrics assessing antibiotic use in the outpatient setting: a global consensus procedure (poster)
  3. Variation in indicators of antibiotic use among and within different settings: a systematic review (poster)
  4. Quality indicators assessing antibiotic use in the outpatient setting: a systematic literature review followed by a consensus procedure (poster)
  5. Quality indicators of antibiotic use in the inpatient setting: a global consensus procedure (slide set)

ESCMID also hosted a special event at ECCMID this year that featured the contributions of SMEs to the antibiotic R&D pipelines. Ursula Theuretzbacher, co-leader of Work Package 3B, ‘Stakeholder platform and external communications’, organised the event and led the session, which gave an overview of the R&D programmes that are driving innovation in this critical space. European, US and Indian companies presenting their programs were well received.